NAUTILUS BIOTECHNOLOGY INC. - COMMON STOCK

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

18 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 Feb 2025 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

31 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

30 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

29 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

08 Oct 2024 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

17 Sep 2024 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

14 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

30 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

09 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

23 May 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

11 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28 Feb 2024 07:00:01 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

07 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

30 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

01 Nov 2023 07:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

31 Oct 2023 07:05:00 By Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023

11 Oct 2023 07:05:00 By Nasdaq GlobeNewswire